scout.yahoo.com
Yahoo Scout
Yahoo Scout
biontech china
Searching…
Web results
www.nature.com
BioNTech boosts oncology pipeline with China buy - Nature
Dec 11, 2024 · One year after partnering with clinical-stage Biotheus on a bispecific antibody targeting PD-L1 and VEGF-A, BioNTech announced the acquisition of the Zhuhai, China–based company for $800...
www.biontech.com
BioNTech's locations and subsidiaries at a glance
Explore BioNTech's global site network and subsidiaries, integrating capabilities from discovery to delivery to pioneer novel immunotherapies and vaccines.
investors.biontech.de
BioNTech and Fosun Pharma to Supply China with mRNA-based ...
Dec 16, 2020 · In March 2020, BioNTech and Fosun Pharma announced their strategic collaboration to work jointly on the development and commercialization of a potential COVID-19 vaccine based on BioNTech’s mRNA technol...
pharmaboardroom.com
BioNTech: Betting Big on Chinese Oncology Innovation
Dec 6, 2025 · Once a little-known mRNA pioneer, BioNTech became a household name with its COVID-19 vaccine developed alongside Pfizer. But the German biotech is now pursuing an even bigger transformation — and China i...
www.yicaiglobal.com
BioNTech to Acquire China’s Biotheus for USD800 Million
Nov 14, 2024 · (Yicai) Nov. 14 -- BioNTech has agreed buy Chinese biopharmaceutical firm Biotheus for USD800 million to strengthen its oncology drugs pipeline.
www.reuters.com
BioNTech buys China's Biotheus to support oncology strategy
Nov 13, 2024 · German drugmaker BioNTech has agreed to acquire Chinese biotech company Biotheus to support its oncology strategy and gain full global rights to the bispecific antibody candidate BNT327, it said...
www.pharmaceutical-tech.com
BioNTech and Fosun Pharma to Expand mRNA Vaccine ...
Sep 1, 2025 · In a significant step forward for mRNA vaccine manufacturing in Asia, BioNTech has unveiled plans to expand its strategic partnership with China's Fosun Pharma. This collaboration aims to enhance the pro...